Usually the well-placed deals don't drop much below offering price----wonder who the weak hands are ???? Just people paying underwriters back with commissions & then flushing once the deal breaks the offering price ???
Make sure to do some homework before spitting out errors. ALXN is a US company located in Cheshire, CT. You need to investigate the tax landscape ---start with Section 7874 of the IRS Code. If that is too much work there are reports from bulge bracket players that can lay it all out for you.
Please short shares (or more likely ----buy a few puts) as it sure sounds like you
are very new to the biotech space. It's no surprise that you do not seem to know why ALXN is one of the top few ALL-TIME biotech stocks. Sometimes having a little perspective can help. That doesn't mean that newbies can't be right but --- if you're smart --- examine WHY ALXN has been held very closely. Hopefully you have more than ....P/E training. If it's amazingly possible that you have SOME scientific training then it may make sense to do a little more than simplistic investment "noise" to see what really goes on. You may be a novice & trying to earn your investment wings but this is no med school. When serious $$$ is involved cursory opinions are a dime-a-dozen. It may make sense for you to GET IN THE GAME.....deer in the headlights is no fun.
We shareholders sure hope so ! Hopefully proof is in the pudding vs. little rookie personal press that had announcements of PHASE ONE trials. Little rookie MAY someday know that those "announcements" have not yielded ANY VALUE for over TWENTY YEARS. But as a NEWBIE TO BIOTECH its ok for you to be ....excited. Just PLEASE don't be surprised when THE WORLD yawns at your daily blabber. How would you POSSIBLY know what CHANGES STOCK VALUATIONS ???? $15 BY JUNE 2013 ??? How'd you arrive at THAT ??? Was your diaper clean that day....and you felt....optimistic ???
DON'T WORRY-----we are all aware of your PUMP & DUMP ! Go away you short misinformer ! WE KNOW WHO ARE !
and your point is ???? the people who got stock are the usual syndicate suspects----they pay for research, meetings et al. by doing syndicate deals. The Baker Brothers are a good example of an organization that will do deals to pay for research --- regardless of whether they hold or not.
Leerink was just in the offering---a little payback. As their comments will state if the Valor trial is judged to be successful the stock opens in the midteens+. I highly doubt that they bought the stock---likely a healthcare hedge fund who met with SNSS @ the Cowen Healthcare Conference this week.
Are you familiar with how corporate heads are compensated ? They get paid a salary, a potential bonus (if they hit their targets) & either restricted stock/or options. When the restricted stock or options matures a portion is often IMMEDIATELY sold to satisfy UNCLE SAM who is paid on the taxes the day they come due. Investors have long known this & generally do not give it much of a look.
Hopefully you can feel better now.
how do you possibly reach $60 ???? GSK has been know to often buy shares when the stock gets to the mid $30s. Wall Street has not been pleased with the Breo rollout & the splitting into 2 companies is not going over all that well either unfortunately.
Just taking in the shares from the offering that were bought to pay back commissions to underwriters. All is well & the offering price will likely prove to be the near term support. The CEO speaks today at the Cowen Healthcare Conference.
oh so you spoke to the baker boys about their interest in the offering ??? anyone who would make such a bogus claim is way out on a cliff. clearly you have syndicate experience as to how deals get done. keep printing the press releases & leave the editorials out ---as you are clearly uneducated & inexperienced in the deal process.